Additionally, a cohort study demonstrated an association between anti-MDA5 IgG1/IgG3 positivity and prognosis in DM-ILD patients, with high anti-MDA5 IgG1 levels confirmed as an independent risk factor for poor prognosis (118). This evidence concerns the gene IFIH1 and dermatomyositis.